InfectiousICD-10: G03About 1.2 million cases of bacterial meningitis occur globally per year

Meningitis

Also known as: Spinal Meningitis

Meningitis is inflammation of the meninges, the membranes that wrap the brain and spinal cord, almost always from a viral or bacterial infection. Bacterial meningitis is a medical emergency that kills about 1 in 10 people even with treatment and can progress from a headache to coma in under 24 hours, so suspected meningitis means calling 911 or going to an emergency department now, not waiting to see. Viral meningitis is more common and usually resolves on its own within 7 to 10 days; no supplement, herb or home remedy treats either form.

Last updated November 10, 2026

Understanding Meningitis

Meningitis is an emergency first and a diagnosis second: if someone has fever with a severe headache, a stiff neck, confusion, drowsiness, a seizure or a rash that does not fade under pressure, the right response is 911 or the nearest emergency department, because bacterial meningitis can kill within hours and every hour before antibiotics worsens the odds. Bacterial meningitis is now uncommon in the United States, about 1.4 cases per 100,000 people a year, around 4,000 cases and 500 deaths, but the case-fatality rate remains near 15 percent in adults even with modern care. Streptococcus pneumoniae causes most cases in adults, Neisseria meningitidis dominates in teenagers and young adults and produces the feared purple rash, group B streptococcus and E. coli affect newborns, and Listeria matters over 50 and in pregnancy. Haemophilus influenzae type b, once the leading cause in toddlers, has fallen by more than 99 percent since the vaccine. Viral meningitis, usually from summer enteroviruses or herpes simplex type 2, is several times more common and almost always survivable.

Bacteria typically colonize the nose and throat, enter the bloodstream, and cross the blood-brain barrier into the cerebrospinal fluid, a space with almost no immune defenses where they multiply unchecked. The resulting inflammation causes the symptoms: swelling raises pressure inside the skull (headache, vomiting, drowsiness, coma), the irritated meninges make neck flexion painful, inflamed vessels clot or bleed, and in meningococcal disease the bacteria's endotoxin triggers widespread clotting and leaking capillaries, which is the rash and the shock. The classic triad of fever, neck stiffness and altered mental status is present in fewer than half of adults, but 95 percent have at least two of headache, fever, neck stiffness and confusion. In a British study of 448 children and teenagers with meningococcal disease, leg pain, cold hands and feet and mottled skin appeared at a median of 8 hours, whereas rash, neck stiffness and confusion arrived at 13 to 22 hours, by which point many were critically ill. About 20 percent of survivors of bacterial meningitis are left with lasting problems, most often hearing loss, learning difficulties and seizures; viral meningitis leaves fatigue and headaches for weeks but rarely permanent harm.

Management follows the Infectious Diseases Society of America guideline and its 2016 European counterpart: blood cultures, then immediate intravenous antibiotics, typically ceftriaxone plus vancomycin, with ampicillin added over age 50, in pregnancy or immunosuppression to cover Listeria, and dexamethasone just before or with the first antibiotic dose. In a 301-patient Dutch trial, dexamethasone cut unfavorable outcomes from 25 to 15 percent and deaths from 15 to 7 percent, and a Cochrane review confirmed it reduces hearing loss and neurological damage, mostly in pneumococcal disease. A lumbar puncture confirms the diagnosis but must never delay antibiotics; when a CT scan is needed first (focal weakness, new seizures, severe immunosuppression, papilledema or reduced consciousness), antibiotics go in before the scan. Close contacts of a meningococcal case get a single dose of ciprofloxacin, rifampin or ceftriaxone within 24 hours. Prevention is vaccination: MenACWY at 11 to 12 with a booster at 16, MenB at 16 to 23 by shared decision, pneumococcal conjugate vaccines for infants and all adults from 50, and Hib in infancy. Viral meningitis is treated supportively, with acyclovir when herpes is suspected.

There is no natural treatment for meningitis, and it is important to say that without hedging: no supplement, herb, essential oil, homeopathic remedy, elderberry syrup, colloidal silver, high-dose vitamin C or intravenous vitamin infusion treats, slows or prevents bacterial or viral meningitis, and no such product is listed on this page. Time spent on any of them while symptoms progress is time that decides whether someone survives with their hearing intact. The same applies to prevention: vaccines are the only interventions with evidence, and they are among the most effective in medicine; the Hib vaccine alone eliminated roughly 20,000 US cases of invasive disease a year. Where diet and lifestyle have a legitimate, modest role is in the long recovery that follows. Fatigue, poor concentration, headaches and low mood commonly last 3 to 6 months after bacterial meningitis and several weeks after viral meningitis, and the measures with evidence are ordinary ones: a graded return to activity, adequate sleep, a hearing test within 4 weeks of discharge with cochlear implant assessment if hearing is lost, and treatment of depression or post-traumatic stress, which affect many survivors and their families.

The most common fatal mistake is waiting to see. Early meningitis looks like flu: fever, aches, headache, vomiting. People take acetaminophen, go to bed and plan to reassess in the morning, and the median time from first symptom to hospital admission in meningococcal disease is around 19 hours. The rule is simple: if a fever comes with a headache severe enough to be the worst of your life, a neck too stiff to touch chin to chest, confusion or unusual sleepiness, a seizure, or any new rash, go now, and if a person cannot be woken or a rash is spreading, call 911. Press a clear glass against the spots; a rash that stays visible through the glass is a bleed into the skin and an emergency, but do not wait for a rash, since about a third of meningococcal cases never develop one and pneumococcal meningitis has none. A second mistake is assuming vaccination makes meningitis impossible: MenACWY does not cover group B, which causes most college outbreaks, pneumococcal vaccines do not cover every strain, and immunity wanes, which is why the age 16 booster exists.

At a Glance

Common symptoms
Sudden high fever, Severe headache, Stiff neck (nuchal rigidity)
Main treatments
Empiric intravenous antibiotics (ceftriaxone, vancomycin) started immediately for suspected bacterial meningitis, Dexamethasone to reduce inflammation and improve outcomes, Antiviral therapy (acyclovir) for herpes simplex meningitis
Category
Infectious · About 1.2 million cases of bacterial meningitis occur globally per year
See a doctor if
Sudden onset of severe headache, fever, and stiff neck

Symptoms

Sudden high fever
Severe headache
Stiff neck (nuchal rigidity)
Nausea and vomiting
Sensitivity to light (photophobia)
Altered mental status or confusion
Seizures
Petechial or purpuric rash (in meningococcal meningitis)
Bulging fontanelle in infants

Causes

  • Bacterial infection (Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae)
  • Viral infection (enteroviruses, herpes simplex virus, mumps)
  • Fungal infection (Cryptococcus, especially in immunocompromised patients)
  • Non-infectious causes (autoimmune, medication-related, cancer)

Risk Factors

  • Age (infants, teenagers, and young adults)
  • Living in close quarters (dormitories, military barracks)
  • Not vaccinated against meningococcal, pneumococcal, or Hib bacteria
  • Immunocompromised status (HIV, organ transplant, splenectomy)
  • Travel to the meningitis belt of sub-Saharan Africa

Diagnosis

  • Lumbar puncture (spinal tap) with cerebrospinal fluid analysis
  • Blood cultures
  • Complete blood count and inflammatory markers (CRP, procalcitonin)
  • CT or MRI of the head before lumbar puncture if indicated
  • PCR testing of CSF for specific pathogens

Treatment

  • Empiric intravenous antibiotics (ceftriaxone, vancomycin) started immediately for suspected bacterial meningitis
  • Dexamethasone to reduce inflammation and improve outcomes
  • Antiviral therapy (acyclovir) for herpes simplex meningitis
  • Supportive care with IV fluids, pain management, and monitoring
  • ICU admission for severe bacterial meningitis

What matters day to day

  • Make sure teenagers get both meningococcal vaccines: MenACWY at 11 to 12 with a booster at 16, and MenB from 16 to 23 (ideally 16 to 18), because MenB causes most US college outbreaks and is not in the MenACWY shot; a combined MenABCWY vaccine is now available for those due both.
  • Ask about pneumococcal vaccination if you are 50 or older or have diabetes, lung, heart, liver or kidney disease, no spleen, a cochlear implant or a weakened immune system: pneumococcus causes more adult meningitis deaths than any other bacterium, and the ACIP lowered the routine age for adults to 50 in 2024.
  • If you are pregnant, over 65 or immunocompromised, avoid unpasteurized milk and soft cheeses, deli meats and hot dogs unless heated steaming hot, and refrigerated smoked seafood and pates: these carry Listeria, the cause of meningitis these groups are uniquely vulnerable to.
  • Do not share drinks, vapes, cigarettes, lip balm or eating utensils in dorms, barracks or shared housing, and get enough sleep: meningococcus spreads by close salivary contact, and crowding, smoking and recent respiratory infections raise carriage and invasive risk.
  • If you have been a close contact of a confirmed meningococcal case (household member, kissing or intimate partner, roommate, anyone who shared utensils or did mouth-to-mouth), seek preventive antibiotics within 24 hours even if you feel well: the attack rate in household contacts is roughly 500 to 800 times the background rate in the following week.
  • After any bacterial meningitis, arrange a hearing test within 4 weeks of leaving hospital (for children, before discharge where possible) and a follow-up at 6 to 8 weeks for fatigue, headaches, memory, mood and, in children, school performance: hearing loss is the most common lasting effect, and cochlear implantation is time-sensitive because the cochlea can ossify within months.

Prevention

  • Meningococcal vaccination (MenACWY and MenB)
  • Pneumococcal vaccination
  • Hib vaccination for infants
  • Prophylactic antibiotics for close contacts of bacterial meningitis cases
  • Good hand hygiene and respiratory etiquette

When to See a Doctor

  • Sudden onset of severe headache, fever, and stiff neck
  • Fever with a non-blanching rash
  • Confusion, drowsiness, or seizures with fever
  • Suspected exposure to a confirmed meningitis case

Frequently Asked Questions

References

  1. Tunkel AR, Hartman BJ, Kaplan SL, et al.; Infectious Diseases Society of America. Practice guidelines for the management of bacterial meningitis. Clinical Infectious Diseases (2004)
  2. van de Beek D, Cabellos C, Dzupova O, et al.. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clinical Microbiology and Infection (2016)
  3. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. New England Journal of Medicine (2004)
  4. de Gans J, van de Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine (2002)
  5. Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews (2015)
  6. Thigpen MC, Whitney CG, Messonnier NE, et al.. Bacterial meningitis in the United States, 1998-2007. New England Journal of Medicine (2011)
  7. Thompson MJ, Ninis N, Perera R, et al.. Clinical recognition of meningococcal disease in children and adolescents. Lancet (2006)
  8. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infectious Diseases (2010)
  9. Mbaeyi SA, Bozio CH, Duffy J, et al.. Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recommendations and Reports (2020)
  10. MedlinePlus. Meningitis (2024)View source
  11. Centers for Disease Control and Prevention. About Bacterial Meningitis (2024)View source

Related Conditions

Have questions about Meningitis?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.